Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congesitive heart failure (CHF). The channel includes news on HFpEF and HFrEF.

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019

The American College of Cardiology (ACC) released a list of the...

FDA Approves 3T Acticor and Rivacor Tachycardia Devices from Biotronik
Technology | Cardiac Resynchronization Therapy Devices (CRT) | March 15, 2019

March 15, 2019 – Biotronik announced U.S. Food and Drug Administration (FDA) approval of the Acticor and Rivacor...

FDA Approves MitraClip for Use in Heart Failure Patients With Functional Mitral Regurgitation
Feature | Heart Valve Technology | March 14, 2019 | Jeff Zagoudis, Associate Editor

March 14, 2019 — The U.S. Food and Drug Administration (FDA) approved the MitraClip...

William T. Abraham, M.D., Joins V-Wave as Chief Medical Officer

William T. Abraham, M.D., in an interview with DAIC Editor Dave Fornell at TCT 2016.

News | Heart Failure | March 12, 2019

March 12, 2019 — V-Wave Ltd. announced that renowned heart failure cardiologist...

FDA Releases Final Guidances on Regenerative Medicine Therapies
News | Stem Cell Therapies | March 04, 2019

March 4, 2019 — The U.S. Food and Drug Administration (FDA) recently finalized two guidance documents regarding...

AT&T Demonstrates Connectivity With Smart Scale at HIMSS 2019
News | Remote Monitoring | February 21, 2019

February 21, 2019 — At the recent Healthcare...

Heart Muscle Cells Created From Stem Cells Beat in Sync
News | Stem Cell Therapies | February 01, 2019

February 1, 2019 — A team of Rutgers scientists have taken an important step toward the goal of making diseased...

A MitraClip case underway at the University of Colorado Hospital hybrid cath lab. Left to right are doctors John Carroll, Edward Gill and Dominik Wiktor.

A MitraClip case underway at the University of Colorado Hospital hybrid cath lab. Left to right are doctors John Carroll, Edward Gill and Dominik Wiktor. 

Blog | University of Colorado Hospital | January 16, 2019

In late December, I had the opportunity to conduct an onsite visit to the...

EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019

January 8, 2019 — A Mayo Clinic study finds that applying...

Aurigen Medical Atrial Fibrillation Device Wins ICI Innovation Award
News | Atrial Fibrillation | December 18, 2018

December 18, 2018 — Irish medical device company AuriGen Medical won the prestigious Global Innovation Award at the...

Interventional procedures have become increasing complex with a shift from open surgical procedures to transcatheter procedures. This is a chronic total occlusion (CTO) case at the University of Colorado to reopen a bypass graft. It shows doctors John Messenger and Kevin Rogers.

Interventional procedures have become increasingly complex with a shift from open surgical procedures to transcatheter procedures. This is a chronic total occlusion (CTO) case at the University of Colorado to reopen a bypass graft.

Blog | December 11, 2018

 

There are numerous factors that impact the larger picture in cardiology, especially from a buiness...

Overlay Init